Kyowa Hakko Kirin News and Activities

Presence

Kyowa Kirin is a pharmaceutical company that develops, makes, and sells prescription medicines and specialty treatments. Its products serve hospitals, clinics, and patients in areas such as oncology, nephrology, immunology, and rare diseases.

Kyowa Hakko Kirin products and services overview:

Prescription medicines
Specialty drugs
Oncology treatments
Rare disease therapies
Immunology therapies
Nephrology treatments

Revenue: ~$3 billion

Employees: 6,000

Headquarters: Tokyo, Japan

Kyowa Hakko Kirin is owned by Kirin.

Kirin is one of the...

Kirin is a company listed under the stock ticker 2503 (JP).

Kirin has a direct presence in 3 countries.

Kirin has 6 subsidiaries including Coca-Cola Beverages Northeast, Kyowa Chemical Industry and Kyowa Hakko Kirin.

They are in:

Executives

View the org chart displaying its 85 main executives

Most searched biographies at Kyowa Hakko Kirin

Popular executive movements at Kyowa Hakko Kirin

Hiroki Nakamura who was Head, Global Corporate Communications, becomes Regional Head of Corporate Communications, Japan and Asia Pacific (posted on May 5 2026).
Koji Igarashi has joined the company as Chief Financial Officer (posted on May 5 2026).
Abdul Mullick, who was Representative Director, President and Chief Operating Officer, is promoted to President and Chief Executive Officer (posted on December 15 2025).

Click here to view some more movements at Kyowa Hakko Kirin

Create your alert
to follow the executive moves at Kyowa Hakko Kirin.